X0407 4 2023-04-10 0 0001832415 Better Therapeutics, Inc. BTTX 0001105941 PERRY DAVID P C/O BETTER THERAPEUTICS, INC. 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 1 1 1 0 See Remarks 0001890678 David P. Perry 2015 Trust C/O BETTER THERAPEUTICS, INC. 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 0 0 1 0 0 Common Stock 2023-04-10 4 P 0 1333333 0.825 A 11797348 I By Perry Trust Common Stock 2023-04-10 4 P 0 3636364 0.825 A 3636364 I By Maule-Ffinch Trust Common Stock 293150 I By spouse Common Stock 21336 I By Pensus Limited Trust Common Stock 101536 D On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the David P. Perry 2015 Trust (the "Perry Trust") acquired 1,333,333 shares of Issuer common stock on April 10, 2023 for $0.825 per share. These shares are owned directly by the Perry Trust, a ten percent owner of the Issuer, and indirectly by David P. Perry ("Perry") as trustee of the Perry Trust. Perry is an officer, director and ten percent owner of the Issuer. As one of the PIPE Investors, the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust") acquired 3,636,364 shares of Issuer common stock on April 10, 2023 for $0.825 per share. These shares are owned directly by the Maule-Ffinch Trust, a ten percent owner of the Issuer, and indirectly by Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), as the sole trustee of the Maule-Ffinch Trust, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by Maule-Ffinch. These shares are owned directly by Donald R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Executive Chairman of the Board of Directors /s/ Mark Heinen, Attorney-in-Fact for David P. Perry 2023-04-12 /s/ Mark Heinen, Attorney-in-Fact for David P. Perry 2015 Trust 2023-04-12